Cargando…

Early Lifetime Substance Use and Development of Visual Impairment: Analysis of the National Survey on Drug Use and Health Data

PURPOSE: To investigate the association between early lifetime substance use on the development of severe visual acuity impairment or blindness on a national level. METHODS: National Survey of Drug Use and Health data was used to identify cases of substance use before 21* years of age, within the pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Hussain, Zain S, Khan, Asher, Loya, Asad, Shah, Kaushal, Woreta, Fasika A, Riaz, Kamran M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10030542/
https://www.ncbi.nlm.nih.gov/pubmed/36968284
http://dx.doi.org/10.2147/OPTH.S401167
_version_ 1784910399395594240
author Hussain, Zain S
Khan, Asher
Loya, Asad
Shah, Kaushal
Woreta, Fasika A
Riaz, Kamran M
author_facet Hussain, Zain S
Khan, Asher
Loya, Asad
Shah, Kaushal
Woreta, Fasika A
Riaz, Kamran M
author_sort Hussain, Zain S
collection PubMed
description PURPOSE: To investigate the association between early lifetime substance use on the development of severe visual acuity impairment or blindness on a national level. METHODS: National Survey of Drug Use and Health data was used to identify cases of substance use before 21* years of age, within the past year, and cases of self-reported blindness or visual impairment. Univariable and multivariable binary logistic regression with time-dependency was performed to evaluate odds of visual impairment influenced by 16 substances separated into three classes: prescription, non-prescription, and illicit drugs. Adjusted variables of interest included gender, marital status, race, level of education, total family income, poverty level, population density, and history of chronic disease. RESULTS: 55,824 total responses were analyzed with 2577 (4.6%) cases of self-reported blindness or significant visual impairment. All early-use substance categories, including prescription, non-prescription, and illegal substances, were significantly associated with self-reported VI (OR 2.068, CI 1.451–2.949, p<0.001; OR 1.352, CI 1.227–1.489, p<0.001); OR 1.211, CI 1.086–1.352, p<0.001), respectively). Non-prescription substances displayed parallel significances amongst all constituents (alcohol, cigarettes, inhalants, and marijuana) (OR=1.227, CI 1.12–1.344, p<0.001; OR 1.363, CI 1.243–1.495, p<0.001; OR 1.418, CI 1.134–1.774; OR 1.388, CI 1.27–1.518, p<0.001, respectively). Univariable and multivariable analysis revealed several significant demographical and clinical adjustors. CONCLUSION: Early lifetime use of all three classes of substances is associated with enhanced odds of subsequent visual impairment or blindness. Several readily available and commonly used substances have a greater risk. These findings may help clinicians and public health agencies in mitigation ventures including education, prevention, and rehabilitation efforts.
format Online
Article
Text
id pubmed-10030542
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-100305422023-03-23 Early Lifetime Substance Use and Development of Visual Impairment: Analysis of the National Survey on Drug Use and Health Data Hussain, Zain S Khan, Asher Loya, Asad Shah, Kaushal Woreta, Fasika A Riaz, Kamran M Clin Ophthalmol Original Research PURPOSE: To investigate the association between early lifetime substance use on the development of severe visual acuity impairment or blindness on a national level. METHODS: National Survey of Drug Use and Health data was used to identify cases of substance use before 21* years of age, within the past year, and cases of self-reported blindness or visual impairment. Univariable and multivariable binary logistic regression with time-dependency was performed to evaluate odds of visual impairment influenced by 16 substances separated into three classes: prescription, non-prescription, and illicit drugs. Adjusted variables of interest included gender, marital status, race, level of education, total family income, poverty level, population density, and history of chronic disease. RESULTS: 55,824 total responses were analyzed with 2577 (4.6%) cases of self-reported blindness or significant visual impairment. All early-use substance categories, including prescription, non-prescription, and illegal substances, were significantly associated with self-reported VI (OR 2.068, CI 1.451–2.949, p<0.001; OR 1.352, CI 1.227–1.489, p<0.001); OR 1.211, CI 1.086–1.352, p<0.001), respectively). Non-prescription substances displayed parallel significances amongst all constituents (alcohol, cigarettes, inhalants, and marijuana) (OR=1.227, CI 1.12–1.344, p<0.001; OR 1.363, CI 1.243–1.495, p<0.001; OR 1.418, CI 1.134–1.774; OR 1.388, CI 1.27–1.518, p<0.001, respectively). Univariable and multivariable analysis revealed several significant demographical and clinical adjustors. CONCLUSION: Early lifetime use of all three classes of substances is associated with enhanced odds of subsequent visual impairment or blindness. Several readily available and commonly used substances have a greater risk. These findings may help clinicians and public health agencies in mitigation ventures including education, prevention, and rehabilitation efforts. Dove 2023-03-14 /pmc/articles/PMC10030542/ /pubmed/36968284 http://dx.doi.org/10.2147/OPTH.S401167 Text en © 2023 Hussain et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Hussain, Zain S
Khan, Asher
Loya, Asad
Shah, Kaushal
Woreta, Fasika A
Riaz, Kamran M
Early Lifetime Substance Use and Development of Visual Impairment: Analysis of the National Survey on Drug Use and Health Data
title Early Lifetime Substance Use and Development of Visual Impairment: Analysis of the National Survey on Drug Use and Health Data
title_full Early Lifetime Substance Use and Development of Visual Impairment: Analysis of the National Survey on Drug Use and Health Data
title_fullStr Early Lifetime Substance Use and Development of Visual Impairment: Analysis of the National Survey on Drug Use and Health Data
title_full_unstemmed Early Lifetime Substance Use and Development of Visual Impairment: Analysis of the National Survey on Drug Use and Health Data
title_short Early Lifetime Substance Use and Development of Visual Impairment: Analysis of the National Survey on Drug Use and Health Data
title_sort early lifetime substance use and development of visual impairment: analysis of the national survey on drug use and health data
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10030542/
https://www.ncbi.nlm.nih.gov/pubmed/36968284
http://dx.doi.org/10.2147/OPTH.S401167
work_keys_str_mv AT hussainzains earlylifetimesubstanceuseanddevelopmentofvisualimpairmentanalysisofthenationalsurveyondruguseandhealthdata
AT khanasher earlylifetimesubstanceuseanddevelopmentofvisualimpairmentanalysisofthenationalsurveyondruguseandhealthdata
AT loyaasad earlylifetimesubstanceuseanddevelopmentofvisualimpairmentanalysisofthenationalsurveyondruguseandhealthdata
AT shahkaushal earlylifetimesubstanceuseanddevelopmentofvisualimpairmentanalysisofthenationalsurveyondruguseandhealthdata
AT woretafasikaa earlylifetimesubstanceuseanddevelopmentofvisualimpairmentanalysisofthenationalsurveyondruguseandhealthdata
AT riazkamranm earlylifetimesubstanceuseanddevelopmentofvisualimpairmentanalysisofthenationalsurveyondruguseandhealthdata